About Space OAR™

About SpaceOAR™ Hydrogel

A little space before prostate radiation can make a BIG difference after.

In a clinical study, SpaceOAR Hydrogel was shown to help minimise the impact on urinary, sexual and bowel quality of life for prostate cancer patients undergoing radiation therapy. 1,2,3

MORE Space

means FEWER

Bowel Complications

Bladder Complications

Sexual Complications

Which leads to a BETTER QUALITY OF LIFE*

*After radiotherapy was complete, control patients experienced a clinically significant (1xMID) decline in bowel, urinary and sexual quality of life 8 times more often than SpaceOAR Hydrogel patients.3,4

Real Patients, Real Stories

Hear from prostate cancer survivors who have benefited from SpaceOAR Hydrogel as well as from the physicians who provide it to their patients.

More Than 50,000 Patients Worldwide Have Been Treated with SpaceOAR Hydrogel.

More Than 50,000 Patients Worldwide Have Been Treated with SpaceOAR Hydrogel.1

Download a discussion guide to help you talk to your doctor about whether SpaceOAR Hydrogel is right for you.

Download a Discussion Guide

Frequently Asked Questions

Why should I have SpaceOAR Hydrogel?

By pushing the prostate farther from the rectum, the radiation dose delivered to the rectum is reduced, which may lessen damage to the rectum. With SpaceOAR Hydrogel in place, a doctor can complement the patient’s radiation treatment to better target their cancer while preserving healthy tissue to help maintain quality of life.1-3

Is it safe?

SpaceOAR Hydrogel completed CE marking in 2012.

Hydrogel spacer received positive NICE guidance (IPG590) for the reduction of rectal toxicity during radiotherapy for prostate cancer in 2017.5

What is the procedure like and how long will it stay in my body?

SpaceOAR Hydrogel is injected as a liquid through a needle inserted between the rectum and the prostate. It can be implanted via a local anesthetic that will numb the injection area or under general anesthesia that will put a patient to sleep during the procedure. SpaceOAR Hydrogel stays in place for about three months and is naturally absorbed into the body and removed through urine in about 6 months. SpaceOAR Hydrogel can be implanted during an outpatient procedure in a hospital, surgery center, outpatient clinic or doctor’s office prior to the start of radiation treatment. It is typically not a lengthy procedure – usually about 30 minutes.2

Watch a video animation

What are the risks?

As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with SpaceOAR hydrogel injection; pain or discomfort associated with SpaceOAR Hydrogel; needle penetration of the bladder, prostate, rectal wall, rectum, or urethra; injection of SpaceOAR Hydrogel into the bladder, prostate, rectal wall, rectum, or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR Hydrogel intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; constipation; and rectal urgency.

Find a doctor who offers SpaceOAR Hydrogel near you.

Find a doctor who offers SpaceOAR Hydrogel near you.

You will be redirected to a map view showing you the nearest hospital to your location.

Find a doctor

Have more questions?


 

Contact us

The content of this website is for information purposes only and not meant for product promotion or medical diagnostic. This information does not constitute medical or legal advice, and Boston Scientific makes no representation or warranty regarding this information or its completeness, accuracy or timeliness. Accordingly, Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health or to address any questions.

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary. As with any medical treatment, there are some risks involved with the use of SpaceOAR Hydrogel. Potential complications associated with SpaceOAR Hydrogel include, but are not limited to: pain associated with SpaceOAR Hydrogel injection; pain or discomfort associated with SpaceOAR Hydrogel; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR Hydrogel into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR Hydrogel intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.

References

  1. Data on file with Boston Scientific.
  2. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.
  3. Hamstra DA, Mariados N, Sylvester J, et al. Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial. Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):976-85.
  4. Hamstra D, Shah D, Kurtzman S, et al. Evaluation of sexual function on a randomized trial of a prostate rectal spacer. J Clin Oncol. 2017 February 20;35(Suppl 6):69.
  5. Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer (IPG590)
    Evidence-based recommendations on biodegradable spacer insertion (gel or balloon) to reduce rectal toxicity during radiotherapy for prostate cancer in adults.
    Published 23 August 2017